Haifeng Jiang

机构：Huazhong University of Science and Technology · ORCID：0000-0003-3338-4808

发表论文 43 篇 · 总被引 779 次 · h-index 12

代表论文

• Piperlongumine conquers temozolomide chemoradiotherapy resistance to achieve immune cure in refractory glioblastoma via boosting oxidative stress-inflamation-CD8+-T cell immunity (2023 · Journal of Experimental & Clinical Cancer Research · 被引 30)
• Role of chemokine receptor 2 in rheumatoid arthritis: A research update (2023 · International Immunopharmacology · 被引 13)
• DPY30 Promotes Proliferation and Cell Cycle Progression of Colorectal Cancer Cells via Mediating H3K4 Trimethylation (2023 · International Journal of Medical Sciences · 被引 12)
• Effects of IL-6R Expression on IL-6/STAT3/HIF-1α Signaling Pathway in a Mouse Model of Parkinson's Disease with Type 2 Diabetes Co-Morbidity (2024 · Discovery Medicine · 被引 11)
• Predictive value of radiomics-based machine learning for the disease-free survival in breast cancer: a systematic review and meta-analysis (2023 · Frontiers in Oncology · 被引 11)
• CD73 inhibitor AB680 suppresses glioblastoma in mice by inhibiting purine metabolism and promoting P2RY12+ microglia transformation (2025 · Acta Pharmacologica Sinica · 被引 10)